Company intelligence / Profile preview

Swedish Herbal Institute

Laholm , Halland County , Sweden [1][9]pmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~8
Development stage: Phase 2

Overview

Swedish Herbal Institute’s lead product Kan Jang® is a fixed herbal combination of Andrographis paniculata and Eleutherococcus senticosus with demonstrated antiviral, immunomodulatory, and anti-inflammatory effects. It has undergone at least one Phase 2/3 clinical trial for mild COVID‑19. Other products target stress reduction and general wellness using well-documented adaptogens such as Rhodiola rosea (“Arctic Root”) and Schisandra chinensis[5][6][7].

Therapeutic areas: ImmunologyPsychiatryInfectious Diseases
Modalities: Plant-based compounds (herbal extracts, adaptogens)
Industry: Biotech

Drug pipeline

2 assets

Kan Jang

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Swedish Herbal Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Swedish Herbal Institute.

Explore the full profile